Gary Silverman
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Molecular Biology, GeneticsGoogle:
"Gary Silverman"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Li J, Moretti F, Hidvegi T, et al. (2024) Multiple genes core to ERAD, macro-autophagy and lysosomal degradation pathways participate in the proteostasis response in α1-antitrypsin deficiency. Cellular and Molecular Gastroenterology and Hepatology |
| Shi Q, Pei F, Silverman GA, et al. (2020) Mechanisms of Action of Autophagy Modulators Dissected by Quantitative Systems Pharmacology Analysis. International Journal of Molecular Sciences. 21 |
| Wang S, Luke C, Shi V, et al. (2020) Abstract 2426: SERPINB3 promotes radiation resistance in cervical cancer by inhibiting lysosome-mediated cell death Cancer Research. 80: 2426-2426 |
| Wang Y, Cobanoglu MC, Li J, et al. (2019) An analog of glibenclamide selectively enhances autophagic degradation of misfolded α1-antitrypsin Z. Plos One. 14: e0209748 |
| Cummings EE, O'Reilly LP, King DE, et al. (2015) Deficient and Null Variants of SERPINA1 Are Proteotoxic in a Caenorhabditis elegans Model of α1-Antitrypsin Deficiency. Plos One. 10: e0141542 |
| Long OS, Benson JA, Kwak JH, et al. (2014) A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover. Human Molecular Genetics. 23: 5109-22 |
| O'Reilly LP, Long OS, Cobanoglu MC, et al. (2014) A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency. Human Molecular Genetics. 23: 5123-32 |
| Li J, Pak SC, O'Reilly LP, et al. (2014) Fluphenazine reduces proteotoxicity in C. elegans and mammalian models of alpha-1-antitrypsin deficiency. Plos One. 9: e87260 |
| O'Reilly LP, Perlmutter DH, Silverman GA, et al. (2014) α1-antitrypsin deficiency and the hepatocytes - an elegans solution to drug discovery. The International Journal of Biochemistry & Cell Biology. 47: 109-12 |
| O'Reilly LP, Luke CJ, Perlmutter DH, et al. (2014) C. elegans in high-throughput drug discovery. Advanced Drug Delivery Reviews. 69: 247-53 |